News Releases

Click here to access press releases from Astellas Pharma Inc. located in Tokyo, Japan.

Get News Alerts by Email

May 15, 2018

Astellas Appoints Bernhardt Zeiher, M.D., as New Chief Medical Officer

Joins Company's Executive Leadership Team
- Photos 1
May 7, 2018

FDA Approves Supplemental New Drug Application for Myrbetriq® (mirabegron) for Use in Combination with solifenacin succinate for the Treatment of Overactive Bladder Symptoms
May 2, 2018

Astellas Included in Forbes Best Midsize Employers List for Fourth Year
Apr 30, 2018

Astellas' Nahrin Marino named a 2018 Healthcare Businesswomen's Association Luminary
- Photos 1
Apr 26, 2018

Astellas Reports Financial Results for FY2017
Apr 23, 2018

Astellas Submits New Drug Applications for Approval of Gilteritinib for the Treatment of FLT3mut+ Relapsed or Refractory Acute Myeloid Leukemia
Apr 18, 2018

Astellas Announces Sale of Certain Agensys Research Facilities to Kite, a Gilead Company

Asset Transfer was Completed on April 12, 2018
- Photos 1
Apr 3, 2018

Astellas Named "Outstanding Employer" for Supporting Employees with Military Service
- Photos 1
Mar 28, 2018

Astellas Names Tatjana Dragovic, J.D. Head of Ethics & Compliance

Dragovic was previously Vice President, Ethics & Compliance Americas
- Photos 1
Mar 26, 2018

Astellas and Seattle Genetics Receive FDA Breakthrough Therapy Designation for Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer

Show per page